Authors:
Fabre, N
Rustan, I
de Hoffmann, E
Quetin-Leclercq, J
Citation: N. Fabre et al., Determination of flavone, flavonol, and flavanone aglycones by negative ion liquid chromatography electrospray ion trap mass spectrometry, J AM SOC M, 12(6), 2001, pp. 707-715
Authors:
Rascol, O
Arnulf, I
Paul, HPS
Brefel-Courbon, C
Vidailhet, M
Thalamas, C
Bonnet, AM
Descombes, S
Bejjani, B
Fabre, N
Montastruc, JL
Agid, Y
Citation: O. Rascol et al., Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease, MOVEMENT D, 16(4), 2001, pp. 708-713
Authors:
Rascol, O
Nutt, JG
Blin, O
Goetz, CG
Trugman, JM
Soubrouillard, C
Carter, JH
Currie, LJ
Fabre, N
Thalamas, C
Giardina, WJ
Wright, S
Citation: O. Rascol et al., Induction by dopamine D-1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease, ARCH NEUROL, 58(2), 2001, pp. 249-254
Authors:
Sabatini, U
Boulanouar, K
Fabre, N
Martin, F
Carel, C
Colonnese, C
Bozzao, L
Berry, I
Montastruc, JL
Chollet, F
Rascol, O
Citation: U. Sabatini et al., Cortical motor reorganization in akinetic patients with Parkinson's disease - A functional MRI study, BRAIN, 123, 2000, pp. 394-403
Authors:
Agid, Y
Destee, A
Durif, F
Montastruc, JL
Pedarriosse, AM
Deptula, D
Hoffman-La Roche, F
Pollak, P
Bonnet, AM
Allain, H
le Cavorzin, P
Barroche, G
Blin, O
Cesaro, P
Chazot, G
Broussolle, E
Leduc, V
Debilly, B
Feve, JR
Geraud, G
Fabre, N
Gu, C
Gil, R
Henry, P
Tison, F
Ansquer, O
Brefel, C
Payen, I
Said, G
Plante, V
Touchon, J
Cesari, JB
Camu, W
Bennys, K
Viallet, F
Warter, JM
Tranchant, C
Ziegler, M
Citation: Y. Agid et al., Efficacy and tolerability of tolcapone compared with bromocriptine in levodopa-treated parkinsonian patients, MOVEMENT D, 14(1), 1999, pp. 38-44